Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kathryn E. Falberg currently holds 16,900 shares of Jazz Pharmaceuticals plc (JAZZ), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kathryn E. Falberg has been a net seller of JAZZ stock. They have purchased $13.3M and sold $77.9M worth of shares.
Kathryn E. Falberg's most recent insider trade was on Jun 11, 2026, when they sold 16,900 shares at $0.00 per share.
Kathryn E. Falberg serves as Executive at Jazz Pharmaceuticals plc (JAZZ). They have executed 174 insider transactions totaling $91.3M over their tenure at the company.
Kathryn E. Falberg holds the position of Executive at Jazz Pharmaceuticals plc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Kathryn E. Falberg has shown a selling trading pattern, with $13.3M in total purchases and $77.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kathryn E. Falberg was on Aug 13, 2024, when they sold $14.7M worth of TTD shares. This transaction involved 150,000 shares at $98.17 per share.
Kathryn E. Falberg currently owns 16,900 shares of Jazz Pharmaceuticals plc (JAZZ), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kathryn E. Falberg's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kathryn E. Falberg has 174 Form 4 filings on record as an insider at Jazz Pharmaceuticals plc.
Set alerts for Kathryn E. Falberg and 40,000+ other insiders.